Please wait while we open this resource.
K
Clinical reviews
POST-TRANSPLANTATION CYCLOPHOSPHAMIDE AND ANTHYMOCTE GLOBULIN IN 8/10 HLA-MISMATCHED UNRELATED DONOR TRANSPLANTATION
null
PDF202510 pages978 KB
Allogeneic hematopoietic cell transplantation (alloHCT) from 8/10 HLA-matched unrelated donors is performed in a minority of patients. There is little data on its outcomes and consequently, guidelines on optimal transplantation procedures are lacking. The Transplant Complications Working Party of the EBMT performed a registry study comparing various outcomes in this context, aiming to provide insights into the efficacy and safety of these transplantation methods.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Myeloproliferative Neoplasms
Same clinical topic · Hematology
MASTOCYTOSIS
Same clinical topic · Hematology
MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology
PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology
COMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
Same clinical topic · Hematology
VEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIES
Same clinical topic · Hematology
IRON DEFICIENCY
Same clinical topic · Hematology
MULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENT
Same clinical topic · Hematology
ANTIDOTES FOR ANTICOAGULATION REVERSAL
Same clinical topic · Hematology